- Home
- ALXO vs EDRY Comparison
ALXO vs EDRY Comparison
Compare ALXO & EDRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALXO
- EDRY
- Stock Information
- Founded
- ALXO 2015
- EDRY 2018
- Country
- ALXO United States
- EDRY Greece
- Employees
- ALXO N/A
- EDRY N/A
- Industry
- ALXO Biotechnology: Pharmaceutical Preparations
- EDRY Marine Transportation
- Sector
- ALXO Health Care
- EDRY Consumer Discretionary
- Exchange
- ALXO Nasdaq
- EDRY Nasdaq
- Market Cap
- ALXO 28.3M
- EDRY 24.6M
- IPO Year
- ALXO 2020
- EDRY N/A
- Fundamental
- Price
- ALXO $0.42
- EDRY $8.76
- Analyst Decision
- ALXO Strong Buy
- EDRY
- Analyst Count
- ALXO 6
- EDRY 0
- Target Price
- ALXO $3.54
- EDRY N/A
- AVG Volume (30 Days)
- ALXO 515.3K
- EDRY 3.5K
- Earning Date
- ALXO 05-08-2025
- EDRY 05-20-2025
- Dividend Yield
- ALXO N/A
- EDRY N/A
- EPS Growth
- ALXO N/A
- EDRY N/A
- EPS
- ALXO N/A
- EDRY N/A
- Revenue
- ALXO N/A
- EDRY $61,083,227.00
- Revenue This Year
- ALXO N/A
- EDRY N/A
- Revenue Next Year
- ALXO N/A
- EDRY $42.57
- P/E Ratio
- ALXO N/A
- EDRY N/A
- Revenue Growth
- ALXO N/A
- EDRY 28.35
- 52 Week Low
- ALXO $0.44
- EDRY $8.00
- 52 Week High
- ALXO $17.50
- EDRY $24.84
- Technical
- Relative Strength Index (RSI)
- ALXO 31.14
- EDRY 43.13
- Support Level
- ALXO $0.49
- EDRY $8.50
- Resistance Level
- ALXO $0.55
- EDRY $8.85
- Average True Range (ATR)
- ALXO 0.05
- EDRY 0.27
- MACD
- ALXO 0.00
- EDRY 0.07
- Stochastic Oscillator
- ALXO 4.92
- EDRY 32.91
About ALXO ALX Oncology Holdings Inc.
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.
About EDRY EuroDry Ltd.
EuroDry Ltd is a holding company. It is a provider of ocean-going transportation. The company owns and operates dry bulk carriers that transport bulks such as iron ore, coal, and grains, and minor bulks such as bauxite, phosphate, and fertilizers.